Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Secondary Hemophagocytic Lymphohistiocytosis (sHLH) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Secondary Hemophagocytic Lymphohistiocytosis (sHLH) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The study to evaluate the effect of cyclosporine ( IL2 inhibitor and antiviral) verse standard care treatment on decrease ADRS, hyper inflammation, hypercytokin…
Macrophage Activation Syndrome (MAS) is a rare, life-threatening condition characterized by uncontrolled hyperinflammation which may develop on the background o…